track injection sites semaglutide How to Inject Your Semaglutide/Tirzepatide (GLP-1 Analogs) Semaglutide Injection Sites: Clinical Guidance

Compound Receptors Peak trial weight loss Lean mass as share of loss Semaglutide (Ozempic/Wegovy) GLP-1 ~14.9% (STEP-1, 68 wk) ~39% Tirzepatide (Mounjaro/Zepbound) GLP-1 + GIP ~20.9% (SURMOUNT-1, 72 wk) ~25-40% Retatrutide GLP-1 + GIP + GCGR ~24.2% (Phase 2, 48 wk) Comparable class range Best for understanding the takeaway: the percentage of loss that is lean mass is roughly constant across the class

Who loses

This means that about half of employees have access, but the other half do not, creating a significant gap between demand and availability

Because it's structurally identical, it binds to pituitary receptors and encourages a release of growth hormone that mimics the bodys natural pulse